Diabetes Technology Society, Burlingame, CA, USA.
Krouwer Consulting, Sherborn, MA, USA.
J Diabetes Sci Technol. 2023 Nov;17(6):1676-1685. doi: 10.1177/19322968221105895. Epub 2022 Jul 5.
Diabetes management and treatment requires the use of many devices that frequently must puncture the skin, creating a risk of unintentional retention in the body as a retained diabetes device. In this article, we reviewed case studies about retained diabetes devices and presented analyses of the success rate of current imaging techniques in identifying retained devices and the success rate of device removal.
PubMed and Google Scholar were searched for articles about retained diabetes devices. Relevant articles that included sufficient details about discovery and removal of the device were included. The success rate of identification and the success rate of removal of retained devices were both calculated as percentages.
Sixteen case studies of retained diabetes devices were identified. These devices included parts of continuous glucose monitors and infusion sets, a lancet, and various types of needles for insulin injection. Each case is presented with details about the year of publication, the retained diabetes device, the company that produced the device, the age and gender of the patient, the type of diabetes that the patient had, the location of the device, the reason for initial discovery of the retained device, the process of locating the device, the success rate for removal of the device, and the removal procedure of the device. Analysis revealed a 100% success rate for the use of imaging technology including X-rays and computed tomography to identify a retained diabetes device. The patients with retained diabetes devices had a 62.5% success rate for eventual removal of the device.
With the increasing use of injected, inserted, and implanted diabetes wearables for digital health, it is likely that some of the devices will detach, break apart, or otherwise become retained in the body. It is important to be aware of available technologies to identify retained diabetes devices so that it will be possible in most cases to surgically remove these devices if they detach or become retained.
糖尿病的管理和治疗需要使用许多经常需要刺破皮肤的设备,这会造成无意将设备留在体内的风险,即留置糖尿病设备。在本文中,我们回顾了关于留置糖尿病设备的病例研究,并对当前成像技术识别留置设备的成功率和设备取出的成功率进行了分析。
在 PubMed 和 Google Scholar 上搜索关于留置糖尿病设备的文章。纳入了包含设备发现和取出详细信息的相关文章。将识别成功率和设备取出成功率均计算为百分比。
共确定了 16 例留置糖尿病设备的病例研究。这些设备包括连续血糖监测器和输注套件的部件、采血针和各种类型的胰岛素注射针。每个病例都详细介绍了发表年份、留置糖尿病设备、设备生产厂家、患者年龄和性别、患者所患糖尿病类型、设备位置、首次发现留置设备的原因、定位设备的过程、取出设备的成功率以及设备取出过程。分析显示,使用包括 X 光和计算机断层扫描在内的成像技术识别留置糖尿病设备的成功率为 100%。有留置糖尿病设备的患者最终取出设备的成功率为 62.5%。
随着用于数字健康的注射、插入和植入式糖尿病可穿戴设备的使用越来越多,其中一些设备可能会脱落、断裂或以其他方式留在体内。了解可用于识别留置糖尿病设备的技术非常重要,以便在大多数情况下,如果这些设备脱落或留置,就有可能通过手术将其取出。